Frontlight ResearchEarly access
WithdrawnPhase 2
Chemo-embolization for Head and Neck Cancer
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 2
- Starts
- May 2027
- Expected to end
- May 2030
- Type of study
- Interventional
- Treatments tested
- Cisplatin
- Record updated
- 27 April 2025
- Why it stopped
- No staff or funding to do the study.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- 1. Provision of signed and dated informed consent form
- 2.Stated willingness to comply with all study procedures and availability for the duration of the study
- 3.Male or female, aged 18 or older
- 4.Diagnosed with squamous cell carcinoma of the Head and Neck
- 5.Ability to undergo chemo-embolization
- 6.For females of reproductive potential: Negative pregnancy test at time of chemo-embolization
- 7.Platinum-ineligible as determined by presence of CTS grade I nephropathy, neuropathy or otopathy, and/or ECOG 2+ performance status
- 8.Plan to undergo standard of care radiation and chemo- and/or immunotherapy
Who cannot take part
- 2. Treatment with a competing investigational drug or intervention trial that does not allow adjuvant chemo-embolization
- 1. Medically unfit to undergo chemo-embolization
Where in United States
- University of Alabama at BirminghamBirmingham, United States
About the trial
What the trial wants to find out
The study will evaluate whether adjuvant chemo-embolization increases progression free and/or overall survival relative to standard of care radiation and chemo- and/or immunotherapy in cisplatin-ineligible head and neck cancer patients with an acceptable morbidity rate.
The group in the trial
- Chemo-embolizationTreatment being tested
Intra-arterial Cisplatin suspension 150-300 mg is infused into the tumor pedicle(s)
Treatment: Cisplatin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 April 2025